Haloperidol aggravates transverse aortic constriction-induced heart failure via mitochondrial dysfunction
Haloperidol is an antipsychotic drug that inhibits the dopamine D2 receptor among others. Haloperidol also binds the sigma-1 receptor (σ1R) and inhibits it irreversibly. A serious outcome of haloperidol treatment of schizophrenia patients is death due to sudden cardiac failure. Although the cause re...
Main Authors: | Yasuharu Shinoda, Hideaki Tagashira, Md. Shenuarin Bhuiyan, Hideyuki Hasegawa, Hiroshi Kanai, Kohji Fukunaga |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-07-01
|
Series: | Journal of Pharmacological Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861316300640 |
Similar Items
-
Sigma-1 receptor is involved in modification of ER-mitochondria proximity and Ca2+ homeostasis in cardiomyocytes
by: Hideaki Tagashira, et al.
Published: (2023-02-01) -
Ginsenoside RH4 inhibits Ang II-induced myocardial remodeling by interfering with NFIL3
by: Yitong Wang, et al.
Published: (2024-03-01) -
Comparison between haloperidol decanoate and oral haloperidol on seeking psychiatric emergency care
by: L. Osaku, et al.
Published: (2022-06-01) -
Haloperidol
by: 982 SIRIM -
Resveratrol prevents Ang II-induced cardiac hypertrophy by inhibition of NF-κB signaling
by: En Ma, et al.
Published: (2023-09-01)